Biomedicines (Aug 2024)

Current Management of Non-ST-Segment Elevation Acute Coronary Syndrome

  • Pablo Díez-Villanueva,
  • César Jiménez-Méndez,
  • Pedro Cepas-Guillén,
  • Andrea Arenas-Loriente,
  • Ignacio Fernández-Herrero,
  • Héctor García-Pardo,
  • Felipe Díez-Delhoyo

DOI
https://doi.org/10.3390/biomedicines12081736
Journal volume & issue
Vol. 12, no. 8
p. 1736

Abstract

Read online

Cardiovascular disease constitutes the leading cause of morbimortality worldwide. Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a common cardiovascular condition, closely related to the ageing population and significantly affecting survival and quality of life. The management of NSTE-ACS requires specific diagnosis and therapeutic strategies, thus highlighting the importance of a personalized approach, including tailored antithrombotic therapies and regimens, combined with timely invasive management. Moreover, specific and frequent populations in clinical practice, such as the elderly and those with chronic kidney disease, pose unique challenges in the management of NSTE-ACS due to their increased risk of ischemic and hemorrhagic complications. In this scenario, comprehensive management strategies and multidisciplinary care are of great importance. Cardiac rehabilitation and optimal management of cardiovascular risk factors are essential elements of secondary prevention since they significantly improve prognosis. This review highlights the need for a personalized approach in the management of NSTE-ACS, especially in vulnerable populations, and emphasizes the importance of precise antithrombotic management together with tailored revascularization strategies, as well as the role of cardiac rehabilitation in NSTE-ACS patients.

Keywords